Pinz Capital Management, LP - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Pinz Capital Management, LP ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2020$132,0008,4640.05%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,466,508$3,783,5915.70%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders